Cargando…

Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin

INTRODUCTION. Numerous studies suggest that total cholesterol content of erythrocyte membranes (CEM) might play a critical role in atherosclerotic plaque progression and instability. However, the exact role of CEM in atherosclerosis remains obscure. Our study was designed to investigate the associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Yucheng, Tang, Hongxia, Zeng, Qiutang, Wang, Xiang, Yi, Guiwen, Meng, Kai, Mao, Yi, Mao, Xiaobo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Informa Healthcare 2012
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497225/ https://www.ncbi.nlm.nih.gov/pubmed/23009223 http://dx.doi.org/10.3109/03009734.2012.672345

Ejemplares similares

Association of the Total Cholesterol Content of Erythrocyte Membranes with the Severity of Disease in Stable Coronary Artery Disease
por: Namazi, Gholamreza, et al.
Publicado: (2014)

Serum Galectin-9 Levels Are Associated with Coronary Artery Disease in Chinese Individuals
por: Zhu, Ruirui, et al.
Publicado: (2015)

Thymic Stromal Lymphopoietin Attenuates the Development of Atherosclerosis in ApoE(−/−) Mice
por: Yu, Kunwu, et al.
Publicado: (2013)

IL-37 Plays a Beneficial Role in Patients with Acute Coronary Syndrome
por: Mao, Xiaobo, et al.
Publicado: (2019)

Lanatoside C Promotes Foam Cell Formation and Atherosclerosis
por: Shi, Huairui, et al.
Publicado: (2016)

Effects of cholesterol on lipid organization in human erythrocyte membrane
Publicado: (1980)

Role of IL-37- and IL-37-Treated Dendritic Cells in Acute Coronary Syndrome
por: Zhu, Ruirui, et al.
Publicado: (2021)

Dramatic Consequences of Reducing Erythrocyte Membrane Cholesterol on Plasmodium falciparum
por: Ahiya, Avantika I., et al.
Publicado: (2022)

The Effects of Cholesterol Oxidation on Erythrocyte Plasma Membranes: A Monolayer Study
por: Lechner, Bob-Dan, et al.
Publicado: (2022)

Association between individual cholesterol and proteinuria response and exposure to atorvastatin or rosuvastatin
por: Kroonen, Marjolein Y. A. M., et al.
Publicado: (2019)

Influence of rosuvastatin dose on total fatty acids and free fatty acids in plasma: Correlations with lipids involved in cholesterol homeostasis
por: Ciucanu, Cristian I., et al.
Publicado: (2020)

A Potential Mechanism of High-Dose Ticagrelor in Modulating Platelet Activity and Atherosclerosis Mediated by Thymic Stromal Lymphopoietin Receptor
por: Mao, Yi, et al.
Publicado: (2015)

Prevalence and prognosis of molecularly defined familial hypercholesterolemia in patients with acute coronary syndrome
por: Wang, Cheng, et al.
Publicado: (2022)

Rosuvastatin Reduces Blood Viscosity in Patients with Acute Coronary Syndrome
por: Jung, Lae-Young, et al.
Publicado: (2016)

Cholesterol Forms and Traditional Lipid Profile for Projection of Atherogenic Dyslipidemia: Lipoprotein Subfractions and Erythrocyte Membrane Cholesterol
por: Uydu, Hüseyin Avni, et al.
Publicado: (2013)

Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe
por: Yamazaki, Daisuke, et al.
Publicado: (2013)

Examination of Physiologically‐Based Pharmacokinetic Models of Rosuvastatin
por: Bowman, Christine M., et al.
Publicado: (2020)

Erratum to: Cholesterol Forms and Traditional Lipid Profile for Projection of Atherogenic Dyslipidemia: Lipoprotein Subfractions and Erythrocyte Membrane Cholesterol
por: Uydu, Hüseyin Avni, et al.
Publicado: (2014)

The effect of rosuvastatin on thromboinflammation in the setting of acute coronary syndrome
por: Sexton, Travis R., et al.
Publicado: (2014)

GARP and GARP-Treated tDC Prevented the Formation of Atherosclerotic Plaques in ApoE(−/-) Mice
por: Cai, Yifan, et al.
Publicado: (2021)

Interleukin‐37 and Dendritic Cells Treated With Interleukin‐37 Plus Troponin I Ameliorate Cardiac Remodeling After Myocardial Infarction
por: Zhu, Ruirui, et al.
Publicado: (2016)

Effect of rosuvastatin on the concentration of each fatty acid in the fraction of free fatty acids and total lipids in human plasma: The role of cholesterol homeostasis
por: Ciucanu, Cristian I., et al.
Publicado: (2020)

Sensitivity of cholecystokinin receptors to membrane cholesterol content
por: Desai, Aditya J., et al.
Publicado: (2012)

Elevated Plasma IL-38 Concentrations in Patients with Acute ST-Segment Elevation Myocardial Infarction and Their Dynamics after Reperfusion Treatment
por: Zhong, Yucheng, et al.
Publicado: (2015)

Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV
por: Courlet, Perrine, et al.
Publicado: (2020)

Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity
por: Ludolph, Barbara, et al.
Publicado: (2007)

Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells
por: Cheng, Min, et al.
Publicado: (2019)

A comparison of the effects of monotherapy with rosuvastatin, atorvastatin or ezetimibe versus combination treatment with rosuvastatin-ezetimibe and atorvastatin-ezetimibe on the integrity of vascular endothelial cells damaged by oxidized cholesterol
por: Niedzielski, Mateusz, et al.
Publicado: (2021)

Effect of streptolysin O on erythrocyte membranes, liposomes, and lipid dispersions. A protein-cholesterol interaction
Publicado: (1975)

Laurdan Discerns Lipid Membrane Hydration and Cholesterol Content
por: Orlikowska-Rzeznik, Hanna, et al.
Publicado: (2023)

MicroRNA-208a Dysregulates Apoptosis Genes Expression and Promotes Cardiomyocyte Apoptosis during Ischemia and Its Silencing Improves Cardiac Function after Myocardial Infarction
por: Tony, Hasahya, et al.
Publicado: (2015)

Gut Microbiome Associates With Lipid-Lowering Effect of Rosuvastatin in Vivo
por: Liu, Yinhui, et al.
Publicado: (2018)

Comparison of Atorvastatin and Rosuvastatin in Reduction of Inflammatory Markers in Acute Coronary Syndrome
por: Umrani, Salman, et al.
Publicado: (2020)

Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients at Cardiovascular Risk
por: Yang, Yujin, et al.
Publicado: (2021)

Effect of Alirocumab and Rosuvastatin or Rosuvastatin Alone on Lipid Core Plaque in Coronary Artery Disease Seen on Near-Infrared Spectroscopy Intravascular Ultrasound (ANTARES)
por: Otake, Hiromasa, et al.
Publicado: (2019)

Combined Effects of Rosuvastatin and Exercise on Gene Expression of Key Molecules Involved in Cholesterol Metabolism in Ovariectomized Rats
por: Ngo Sock, Emilienne Tudor, et al.
Publicado: (2016)

Interleukin-27 Ameliorates Atherosclerosis in ApoE(−/−) Mice through Regulatory T Cell Augmentation and Dendritic Cell Tolerance
por: Xu, Wenbin, et al.
Publicado: (2022)

The asymmetry of plasma membranes and their cholesterol content influence the uptake of cisplatin
por: Rivel, Timothée, et al.
Publicado: (2019)

Cholesterol content regulates silica-induced lysosomal membrane permeability
por: Sydor, Matthew J., et al.
Publicado: (2023)

Current Perspectives on rosuvastatin
por: Hu, Miao, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lcet110sl5et0rc0eub9j17nc8